We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
2151
Scholar Rock
SRRK
$5.92B
$268K ﹤0.01%
5,295
-4,320
-45% -$239K
VSEC icon
2152
VSE Corp
VSEC
$5.59B
$268K ﹤0.01%
+6,794
New +$265K
HOUS
2153
DELISTED
Anywhere Real Estate
HOUS
$266K ﹤0.01%
+17,572
New +$279K
MITT
2154
TPG Mortgage Investment Trust
MITT
$230M
$266K ﹤0.01%
22,031
+15,747
+251% +$179K
IVAN.U
2155
DELISTED
Ivanhoe Capital Acquisition Corp. Unit, each consisting of one Class A ordinary share and one-third
IVAN.U
$266K ﹤0.01%
+25,626
New +$288K
CASS icon
2156
Cass Information Systems
CASS
$720M
$265K ﹤0.01%
+5,723
New +$248K
YPF icon
2157
YPF
YPF
$19.5B
$263K ﹤0.01%
+64,110
New +$271K
CNCE
2158
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$263K ﹤0.01%
52,681
+33,216
+171% +$268K
NMFC icon
2159
New Mountain Finance
NMFC
$668M
$262K ﹤0.01%
21,126
-18,071
-46% -$220K
AXLA
2160
DELISTED
Axcella Health Inc. Common Stock
AXLA
$262K ﹤0.01%
2,205
-207
-9% -$29.2K
ZNH
2161
DELISTED
China Southern Airlines Company Limited
ZNH
$262K ﹤0.01%
7,126
-21,108
-75% -$685K
BLNK icon
2162
Blink Charging
BLNK
$74.1M
$259K ﹤0.01%
+6,304
New +$275K
EWJ icon
2163
iShares MSCI Japan ETF
EWJ
$21.3B
$259K ﹤0.01%
+3,779
New +$262K
FE icon
2164
FirstEnergy
FE
$28.7B
$259K ﹤0.01%
7,458
-26,175
-78% -$855K
SIFY
2165
Sify Technologies
SIFY
$1.03B
$259K ﹤0.01%
+12,229
New +$226K
CVS icon
2166
PUT
CVS Health
CVS
$140B
$256K ﹤0.01%
+3,400
New +$248K
SEGG
2167
Sports Entertainment Gaming Global Corp
SEGG
$13.3M
$256K ﹤0.01%
+107
New +$275K
PRVB
2168
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$256K ﹤0.01%
+24,416
New +$344K
XEL icon
2169
Xcel Energy
XEL
$50.1B
$255K ﹤0.01%
3,838
-62,220
-94% -$3.93M
ALIM
2170
DELISTED
Alimera Sciences
ALIM
$255K ﹤0.01%
+26,515
New +$217K
ENVX icon
2171
Enovix
ENVX
$866M
$254K ﹤0.01%
+21,826
New +$287K
HLMN icon
2172
Hillman Solutions
HLMN
$1.6B
$253K ﹤0.01%
+25,294
New +$265K
PAWZ icon
2173
ProShares Pet Care ETF
PAWZ
$34.4M
$253K ﹤0.01%
+3,500
New +$257K
NWBI icon
2174
Northwest Bancshares
NWBI
$2.33B
$252K ﹤0.01%
+17,421
New +$245K
VRSN icon
2175
VeriSign
VRSN
$25.4B
$252K ﹤0.01%
+1,270
New +$250K

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.